Mammalian hosts coordinate various cell death pathways as part of the immune defense system against pathogens including Mycobacterium tuberculosis ...

FOX 2 - A 100-year-old vaccine is getting a fresh look as it's being studied to treat an autoimmune disease. One local child who's hoping to help change the world for people with type 1 diabetes.

ImmunityBio, Inc. , a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA) has authorized an expanded access program (EAP) that will bring a vital alternative ...

Amid rising respiratory illnesses, a CDC report reveals undetected bird flu cases in US veterinarians. The spread, shown ...

Award-winning science journalist and author Carl Zimmer details the dangers of new viruses, air pollution and wildfires on ...

On-demand video webcast now available here TAMPA, FL / ACCESS Newswire / February 19, 2025 / TuHURA Biosciences, Inc. ("TuHURA"), a Phase 3 registration-stage immune-oncology company developing novel ...

Every year, 10 million people contract tuberculosis (TB), a disease caused by the bacterium Mycobacterium tuberculosis (Mtb), and approximately 1.5 million patients succumb to the disease. Treatment ...

The tuberculosis outbreak in the Kansas City area is not, in fact, the largest in U.S. history. But it does offer an ...

MSI's nominally MSRP RTX 5070 Ti Ventus 3X is a great example of Nvidia's new card. At its $750 price tag it would be the ...

Imagine a breakthrough in cancer treatment where only malignant cells are targeted, sparing healthy host cells; or patients with abnormal protein synthesis are treated to produce a healthy protein.

Our family moved from Orlando, Florida, to Boston last fall. I’m going stir crazy in the winter weather and want to try hiking. As a native Floridian, I’m ...

Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...